Cancer
Malignant Rectal Neoplasm
CI-CAN-00008012Explore in graph →
Top-level388 active trials1 approved drugs5 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00008012Explore in graph →
Clinical trials
1,551 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (153)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01500993 | Capecitabine in the Perioperative Treatment of Rectal Cancer(Rektum-III) | completed | Phase 3 | 401 | Universitätsmedizin MannheimOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT02178644 | Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer | completed | Phase 1 | 29 | Yale UniversityOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT02603757 | Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer | completed | N/A | 70 | Legacy Health SystemOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT04561830 | Open or Laparoscopic Mesolectal Excision in Low Rectum Cancer | completed | N/A | 60 | Zagazig UniversityOTHER_GOV | 0 | Sep 24, 2020 | clinicaltrials |
| NCT00846482 | Exploratory Study Of The ERCC-1 Gene | completed | N/A | 64 | Albert Einstein College of MedicineOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT01397305 | An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer | completed | Phase 1 / Phase 2 | 24 | Isofol Medical ABINDUSTRY | 1 | Sep 9, 2020 | clinicaltrials |
| NCT03996031 | Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic(PTT) | completed | — | 33 | Northwestern UniversityOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT03524716 | Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer II(SmartPaceII) | completed | N/A | 44 | University of California, San FranciscoOTHER | 1 | Aug 27, 2020 | clinicaltrials |
| NCT01634685 | A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma | completed | Phase 1 | 15 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04496765 | Early-onset Rectal Cancer | completed | — | 244 | Mansoura UniversityOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT04488549 | Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19)(DECOR-19) | completed | — | 1,051 | Treviso Regional HospitalNETWORK | 1 | Jul 28, 2020 | clinicaltrials |
| NCT02629315 | Carnoy's Solution Versus Formalin in Rectal and Gastric Cancer Specimens Following: a Randomized Trial | completed | N/A | 130 | Instituto do Cancer do Estado de São PauloOTHER | 0 | Jul 23, 2020 | clinicaltrials |
| NCT04455945 | Quality of Life After Rectal Cancer Surgery | completed | — | 2 | Dr. Lutfi Kirdar Kartal Training and Research HospitalOTHER_GOV | 1 | Jul 2, 2020 | clinicaltrials |
| NCT03200249 | Preoperative Chemo-radiation With IG-IMRT Dose Escalation for Locally Advanced Rectal Cancers(RADICAL) | completed | N/A | 15 | Centre Georges Francois LeclercOTHER | 1 | Jun 24, 2020 | clinicaltrials |
| NCT01363843 | Complete Neoadjuvant Treatment for REctal Cancer (CONTRE) | completed | Phase 2 | 39 | William Sikov MDOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04401787 | Converted Laparoscopic Resection of Upper Rectal Carcinoma T1-4 N0-1 in Obese Patients. | completed | N/A | 156 | Zagazig UniversityOTHER_GOV | 0 | May 26, 2020 | clinicaltrials |
| NCT04096118 | Relationship Between Lymph Node Ratio and Survival Rate in Preoperative Chemoradiation Rectal Cancer Patients | completed | — | 160 | Mahidol UniversityOTHER | 1 | May 11, 2020 | clinicaltrials |
| NCT01643499 | Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies | completed | Phase 1 | 79 | University of ChicagoOTHER | 1 | May 8, 2020 | clinicaltrials |
| NCT01836926 | TaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.(TaTME) | completed | N/A | 110 | Osama Mohammad Ali ElDamshetyOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT04357171 | PReventive cOlostomy vs Ileostomy in Low anTErior reCTal Resection(PROTECT) | completed | N/A | 202 | Russian Society of Colorectal SurgeonsOTHER | 0 | Apr 22, 2020 | clinicaltrials |
| NCT04349384 | Audit of Surgery for Colorectal Cancer(AuditCR) | completed | — | 136 | Institut National d'Oncologie, MoroccoOTHER_GOV | 1 | Apr 16, 2020 | clinicaltrials |
| NCT01674309 | First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis | completed | Phase 2 | 65 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Mar 30, 2020 | clinicaltrials |
| NCT03252821 | Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy | completed | N/A | 78 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Mar 17, 2020 | clinicaltrials |
| NCT01254617 | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer(ADCC) | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2020 | clinicaltrials |
| NCT04293835 | Sigmoid Take-off, New Rectum Definition | completed | — | 835 | Peking University Third HospitalOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT00952926 | Watchful Waiting. An Observational Study of Patients With Rectal Cancer After Concomitant Radiation and Chemotherapy | completed | — | 55 | Vejle HospitalOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT01339273 | Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection | completed | N/A | 72 | Oxford University Hospitals NHS TrustOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT01846520 | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | completed | N/A | 200 | City of Hope Medical CenterOTHER | 1 | Jan 23, 2020 | clinicaltrials |
| NCT01511653 | Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma(GLNE010) | completed | — | 13,000 | University of MichiganOTHER | 3 | Jan 18, 2020 | clinicaltrials |
| NCT01346280 | Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs | completed | — | 1,079 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT00585728 | CT Virtual Proctoscopy for Staging and Volume Assessment for Rectal Cancer | completed | N/A | 20 | University of Wisconsin, MadisonOTHER | 1 | Dec 13, 2019 | clinicaltrials |
| NCT02651701 | Rectal Cancer Staging Using Whole Body MR-PET | completed | — | 71 | Seoul National University HospitalOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT00414232 | Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy | completed | — | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery(BACCHUS) | completed | Phase 2 | 20 | University College, LondonOTHER | 1 | Oct 7, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | completed | Phase 1 | 66 | TG Therapeutics, Inc.INDUSTRY | 1 | Oct 2, 2019 | clinicaltrials |
| NCT03390517 | A Study of Perfusion of Colorectal Anastomosis Using FLuorescence AnGiography (FLAG-trial)(FLAG) | completed | N/A | 377 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Sep 25, 2019 | clinicaltrials |
| NCT03875612 | Radiographic Validation of the Inferior Mesenteric Artery Tie Level in Rectal Cancer Surgery(RAVAL) | completed | — | 98 | Umeå UniversityOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT01802320 | Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery | completed | Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | Sep 20, 2019 | clinicaltrials |
| NCT03265418 | BioXmark, Rectal Feasibility Trial | completed | N/A | 20 | Maastricht Radiation OncologyOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | completed | Phase 2 | 158 | Eli Lilly and CompanyINDUSTRY | 2 | Aug 6, 2019 | clinicaltrials |
| NCT02973672 | Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas | completed | Phase 1 / Phase 2 | 75 | SurgimabINDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT00828672 | Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer(AXEBEAM) | completed | Phase 2 | 84 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT01985763 | Genistein in Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 13 | Sofya PintovaOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT03923309 | Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer | completed | — | 142 | Seoul National University HospitalOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT01206530 | FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer | completed | Phase 1 / Phase 2 | 50 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT03911167 | An Analysis of Clinical Efficacy Based on the Robotic, Laparoscopic, and Open Approach in Radical Resection of Rectal Cancer | completed | — | 24 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03899870 | Factors Predicting Recurrence in Rectal Cancer After Surgery | completed | — | 188 | ammar houssemOTHER | 0 | Apr 2, 2019 | clinicaltrials |
| NCT00645710 | Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery | completed | Phase 1 / Phase 2 | 16 | City of Hope Medical CenterOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT00321685 | Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer | completed | Phase 2 | 57 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Nov 27, 2020source: clinicaltrials